Massachusetts Ballot Donors Pour $8M Into Cannabis, Psychedelics Questions

Psychedelic Therapy Question Leads in Early Fundraising

The campaign supporting Question 4 — the Massachusetts Natural Medicine Act — has raised $5.2 million through September 9, 2026, according to state Office of Campaign and Political Finance (OCPF) filings. The measure would authorize licensed facilities to provide psilocybin-assisted therapy for adults 21 and older, mirroring Oregon's Measure 109 framework. Lead donors include the Healing Advocacy Fund, a national psychedelic-reform PAC, which contributed $2.1 million, and New Approach PAC, which gave $1.8 million.

Opposition to Question 4 remains minimal. The Committee to Protect Massachusetts Families has raised $87,000, primarily from pharmaceutical industry donors and mental-health advocacy groups concerned about clinical oversight gaps.

If approved, the Massachusetts Department of Public Health would issue regulations by July 2027 and begin licensing facilitators and service centers by January 2028. The measure doesn't decriminalize home cultivation or possession outside licensed settings.

Cannabis Tax Cut Draws Industry War Chest

Question 5, the Cannabis Tax Fairness Act, has raised $2.9 million, nearly all from multi-state operators and Massachusetts dispensary chains. The measure would reduce the state excise tax on adult-use cannabis sales from 10.75% to 6.25%, matching the general sales tax rate. Local option taxes of up to 3% would remain unchanged.

Top contributors include Curaleaf ($850,000), Trulieve ($620,000), and Massachusetts-based Cultivate Holdings ($310,000). The Coalition for Responsible Cannabis Policy, the campaign vehicle, argues that the current tax structure — which can reach 20% when combined with local levies — drives consumers to the illicit market and suppresses legal sales.

Opposition comes from the Massachusetts Municipal Association, which warns that the tax cut would cost cities and towns an estimated $65 million annually in shared excise revenue. The opposition campaign has raised $420,000, primarily from municipal employee unions and local government advocacy groups.

Fiscal Impact: $100M Revenue Reduction Projected

The state Department of Revenue projects that Question 5 would reduce combined state and local cannabis tax revenue by $102 million in fiscal 2028, the first full year of implementation. The Cannabis Control Commission's September 2026 revenue forecast estimated total adult-use sales of $1.8 billion in calendar 2027, generating approximately $193 million in state excise tax under the current 10.75% rate.

Cutting the rate to 6.25% would reduce state collections to $112 million, a $81 million decline. Local option tax revenue, currently averaging $21 million annually across 180 host communities, would remain stable under Question 5.

Proponents cite Michigan's experience: that state cut its cannabis excise tax from 10% to 6% in January 2024, and legal sales rose 18% year-over-year through Q2 2024, offsetting most of the per-transaction revenue loss.

National Funders Dominate Both Campaigns

Out-of-state contributions account for 78% of total fundraising across both ballot questions, OCPF data show. The pattern mirrors recent drug-policy campaigns in other states, where national reform groups and industry players supply the bulk of campaign funding.

• New Approach PAC (Oregon): $1.8M to Question 4
• Healing Advocacy Fund (California): $2.1M to Question 4
• Curaleaf (Florida HQ): $850K to Question 5
• Trulieve (Florida HQ): $620K to Question 5

Massachusetts law doesn't cap out-of-state contributions to ballot-question committees, and disclosure requirements mirror candidate campaigns: itemized reporting for donors giving more than $200.

Polling Shows Narrow Margins for Both Measures

A UMass Amherst poll conducted August 15-22, 2026, found Question 4 leading 51%-38%, with 11% undecided, and Question 5 tied at 47%-47%. The psychedelic measure has gained 6 points since a June survey. The cannabis tax question has slipped 3 points as opposition messaging around municipal budget impacts has gained traction.

Ballot questions with narrow September leads and significant opposition funding historically tighten in the final weeks — Massachusetts voters rejected a 2018 nurse-staffing mandate that led polls by 9 points in early October.

Both campaigns have reserved $2.3 million in combined television and digital ad buys for the final six weeks before the November 5 election.

What to Watch: October OCPF Filings and Late Ad Spending

The next campaign finance deadline is October 8, 2026, covering contributions through September 30. Late contributions of $1,000 or more must be disclosed within 48 hours under Massachusetts law, providing real-time visibility into final-stretch funding.

For full background on state-level cannabis ballot measures and their fiscal structures, see the CannIntel topic hub on marijuana legalization ballot initiatives.

Early voting begins October 21. The Massachusetts Secretary of State will certify ballot language by September 20. Turnout in the 2026 midterm is projected at 58% of registered voters, below the 72% who participated in the 2022 gubernatorial election that legalized adult-use cannabis.